Informação da revista
Visitas
254
Review Article
Acesso de texto completo
Disponível online em 22 de setembro de 2025
Genetic aspects of congenital heart disease in heterotaxy syndrome
Aspetos genéticos da cardiopatia congénita na síndrome de heterotaxia
Visitas
254
Nur Nabihah Ahmad Rafiea, Putri Yubbub, Shankar Aissvaryaa, Rajendran Pujitac, Nurul Huda Musaa, Noor Haliza Mohamed Ibrahima, Karuppiah Thilakavathya,d,
a Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
b Department of Pediatrics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
c Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia
d Malaysian Research Institute on Ageing (MyAgeing), Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
Este item recebeu
Recebido 31 Outubro 2022. Aceite 16 Maio 2025
Informação do artigo
Resume
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (2)
Tabelas (6)
Table 1. Summary of the HTX-related genes discussed in this review.
Tabelas
Table 2. DNAH11 variants found to be associated with HTX in previous studies.
Tabelas
Table 3. DNAH5 variants found to be associated with HTX in previous studies.
Tabelas
Table 4. ZIC3 variants found to be associated with HTX in previous studies.
Tabelas
Table 5. NODAL variants found to be associated with HTX in previous studies.
Tabelas
Table 6. LEFTY1 and LEFTY2 variants found to be associated with HTX in previous studies.
Tabelas
Mostrar maisMostrar menos
Abstract

Abnormal arrangement of thoracoabdominal organs, situs ambiguous, is also known as heterotaxy syndrome (HTX). It has been frequently linked with congenital heart diseases (CHD), which are commonly reported as atrioventricular septal defects (AVSD), atrial septal defects (ASD), ventricle septal defects (VSD), transposition of the great artery, and pulmonary stenosis or atresia. Two HTX categories are right atrial isomerism (RAI) and left atrial isomerism (LAI), which are distinguished by the organ's sidedness as well as their complexity. The etiology of the syndrome is being studied widely, where recent studies are more focused on the effect of gene variants present in affected individuals. DNAH11, DNAH5, ZIC3, NODAL, and LEFTY are among the genes studied and associated with HTX. DNAH11 and DNAH5 are associated with ciliary function while ZIC3, NODAL and LEFTY are associated with signaling pathways. As multiple genes are involved, HTX has been reported to have an autosomal dominant, autosomal recessive or X-linked inheritance patterns, depending on the causative genes in the individual. This review aims to summarize several previously reported HTX gene variants, inheritance patterns, as well as the cardiac and extracardiac clinical manifestations.

Keywords:
Heterotaxy syndrome
Isomerism
Genetic variants
Resumo

O arranjo anormal dos órgãos toracoabdominais, situs ambiguus, também é conhecido como síndrome de heterotaxia (HTX). HTX é frequentemente associada a doenças cardíacas congénitas (DCC) que podem ser descritas como defeitos do septo atrioventricular (DSAV), defeitos do septo atrial (DSA), defeitos no septo ventricular (DSV), transposição das grandes artérias (TGA) e estenose pulmonar ou atresia. Duas categorias do HTX são o isomerismo atrial direito (IAD) e isomerismo atrial esquerdo (IAE), que se distinguem pela orientação lateral do órgão, assim como pela sua complexidade. A etiologia desta síndrome está a ser amplamente investigada, onde os estudos mais recentes têm-se focado no efeito de variantes genéticas em indivíduos afetados. DNAH11, DNAH5, ZIC3, NODAL e LEFTY estão entre os genes mais estudados em relação à HTX. DNAH11 e DNAH5 estão associados à função ciliar, enquanto ZIC3, NODAL e LEFTY estão relacionados com vias de sinalização. Uma vez que vários genes estão implicados, a HTX pode apresentar herança autossómica dominante, autossómica recessiva ou ligada ao X, dependendo dos genes causativos. Esta revisão tem como objetivo resumir as diversas variantes genéticas anteriormente descritas e associadas à HTX, bem como padrões de herança e manifestações clínicas cardíacas e extracardíacas.

Palavras-chave:
Síndrome de heterotaxia
Isomerismo
Variantes genéticas
Texto Completo
Introduction

Heterotaxy syndrome (HTX) is an abnormality where internal thoracoabdominal organs are arranged abnormally along the left–right axis of the body, where they diverge from the regular arrangement (situs solitus) and the complete mirror of it (situs inversus)1–3 as depicted in Figure 1. The divergence from the customarily accepted arrangement of left–right patterning is mainly observed in the arrangement of the appendages of the atria and the spleen.2 Any arrangement that is not categorized as situs solitus or situs inversus may be described as situs ambiguous, and this categorization is mainly used for HTX.4

Figure 1.

General arrangement of the thoracoabdominal organs in normal individuals and individuals with situs abnormalities, including HTX. (A) Situs solitus is the normal arrangement of the thoracoabdominal organs. (B) Situs inversus is the complete mirror of situs solitus. (C) Right atrial isomerism with bilateral trilobed lungs, bilateral right atrial appendages, central liver, and asplenia. (D) Left atrial isomerism with bilateral bilobed lungs, bilateral left atrial appendages, central liver, and polysplenia. L: left; LAA: left atrial appendage; R: right; RAA: right atrial appendage.

Congenital heart disease (CHD) is a prevalent birth anomaly, occurring in approximately 8–12 out of every 1000 live births globally.5 HTX is an uncommon birth disorder that affects around 1 out of every 10000 live births, with the majority of them complicated by complex CHD.6 It is noteworthy that there is a higher occurrence of heterotaxy syndrome among individuals with CHD. Research studies have indicated that approximately 5–10% of CHD patients exhibit heterotaxy syndrome.7 The prognostication of the disease, primarily in children with right isomerism with complex congenital defects, has been poor despite the advancement in medical and surgical treatments.8,9

Currently, the diagnosis is made mainly by observing the spleen and the heart morphology prenatally with ultrasound, which is challenging to validate; hence, any observed abnormalities are compared with the abnormalities found postnatally.1 The integration of echocardiography and genetic diagnosis such as whole exome sequencing has been proposed to produce better diagnoses.10

Research on the genetic factors contributing to the association between HTX and CHD is ongoing, and the exact mechanisms are not fully understood. However, there have been some studies indicating potential genetic links between these conditions.6,11–14 Studies have shown that variants in genes causing primary ciliary dyskinesia (PCD) may be associated with the development of HTX with or without CHD.6 For example, variants in the DNAH11 gene have been linked to the development of HTX and CHD.6 Additionally, the presence of copy number variations has also been identified as a genetic basis for HTX and various CHD.13 As further research continues, more genes associated with situs ambiguous are being identified, highlighting the genetic complexity of these conditions.14

Multiple genes have been associated with HTX, with various modes of inheritance, including autosomal recessive, autosomal dominant, and X-linked, have been observed.15 Hence, the aim of this review is to summarize the genes with previously reported variants associated with HTX (DNAH11, DNAH5, ZIC3, NODAL, and LEFTY), their inheritance patterns, and clinical manifestations. These genes are a part of the suggested etiology of HTX, ciliary function as well as signaling pathways.

Heterotaxy syndrome

Two classes of isomerism are used to categorize HTX further. Isomerism is described as the arrangement where organ structures that are supposedly situated on the right or left side of the body are seen on both sides instead.16 The isomeric arrangements may only be seen in certain organs of the individual, and these abnormal arrangement combinations are still considered as isomerism.2

Isomerism in HTX can be divided into two classifications: left atrial isomerism (LAI) and right atrial isomerism (RAI) (Figure 1). However, some patients may manifest both features. When the thoracic or abdominal cavity organs are present with left-sided morphology, it is known as LAI, where it is manifested mainly by left appendages on both sides of the atria, as well as polysplenia, which were reported in more than half of the cases.4 The bilaterally left appendages are described as long and tube-like narrowing at the opening, while the lungs are bilobed with polysplenia.8 In contrast, RAI is right sided with broad-based and triangular shape appendages, trilobed lungs, and absence of the spleen.4

Several retrospective studies focusing on multiple populations have reported more LAI cases in Western countries, while RAI prevalence is greater in Asians.17–20 Two studies which included Germany found more than 50% of the patients reported with LAI.19,20 Another study conducted in the United Kingdom reported almost two times more LAI cases compared to RAI.18 In contrast, in Asian populations, the frequency of RAI was higher than LAI, where the LAI occurrence ratio among HTX patients in Korea, India, Taiwan, and Singapore were all above 0.53.17,21–23 As a result, it is thought future research should focus on the heterogeneity of different populations.17 In addition, HTX with CHD recurrence risk was reported to be as high as 64% in one study.24

Heterotaxy syndrome can have a significant impact on patient outcomes, particularly due to associated complex congenital heart defects and multiorgan dysfunction.25 It can impact various non-cardiac systems, including the immunologic, respiratory, and genitourinary systems, which can affect patient outcomes.26 Morbidity and mortality in patients with HTX remain high despite recent advances in surgical management.8 A study reported by Serraf et al. (2010) states that overall mortality was 20.8%, with 7.2% after the first surgery, 6.6% after the second, and 11.5% after the third.8 Long-term outcomes have not improved since the early 1990s.27 The complexity of underlying CHD in RAI is greater than LAI as the structural defects are more complicated; hence a greater infant mortality was reported.28 Prognostication of a 5-year survival from RAI is worse compared to LAI, where they fall in ranges of 30–74% for RAI and 65–84% for LAI.8

Patients with HTX need a comprehensive management approach; each child will have different needs depending on the nature and severity of the organ involvement. The management and treatment of heterotaxy patients have advanced such as the Ladd procedure for the management of malrotation in children with heterotaxy and CHD, but the prognosis remains unsatisfactory due to the association with complicated CHDs.29 Surgical outcomes in heterotaxy patients have improved in recent years, with low mortality rates after the Fontan operation.30 Proper counseling for the family about the course of the disease, treatment modalities, and outcomes is essential.31 Surgical management of heterotaxy syndrome presents unique challenges, and certain anatomic subsets may require novel strategies.32

Heterotaxy syndrome and congenital heart disease

A spectrum of congenital heart defects had been seen in HTX with distinctive features of systemic and pulmonary venous anomalies, inlet abnormalities and conotruncal defects.33 Most patients with HTX are diagnosed with complex CHD.34 Phenotypic cardiac defect manifestations due to disruption of the left–right asymmetry are complex and extensive.15,35 Complete atrioventricular septal defects (AVSD), atrial septal defects (ASD), ventricle septal defects (VSD), transposition of the great artery, and pulmonary stenosis or atresia are the primary cardiac abnormalities related with RAI.21 On the other hand, LAI patients are more commonly associated with ventricular septal defect, atrial septal defect, and left-sided obstructive lesions.36 LAI patients also have a higher incidence of sinus node dysfunction or heart block compared to RAI patients.37 The occurrence of arrhythmias is more common in LAI patients, with more than half of them experiencing arrhythmias by the age of three.38 The anatomical variants of cardiac structures in heterotaxy patients include abnormal pulmonary veins, low pulmonary blood flow, abnormal relationship of great arteries, and atrioventricular canal defect.39

A study by Ware et al. (2004) on 93 patients reported 28 RAI patients, from among whom 29% showed pulmonary atresia, 46% with pulmonary stenosis, 68% with complete atrioventricular canal, 50% with transposition of the great arteries, and 36% with total anomalous pulmonary venous return, while the percentage of these cardiac defects were lower in LAI at 11%, 33%, 44%, 33%, and 11%, respectively.40 The interrupted inferior vena cava with azygous venous continuation is a constant sign in LAI patients.17 The percentage of levocardia is higher in LAI (89%), while dextrocardia is higher in RAI (46%).21,40 Cardiac abnormalities linked to RAI and LAI are quite similar; however, complex cardiac malformation was shown to be less common in LAI than in RAI.17,21 Besides, there are overlapping of cardiac defects associated with RAI and LAI reported such as atrioventricular septal defects, double outlet right ventricle, transposition of the great arteries and pulmonary stenosis.21

Heterotaxy syndrome is complex and diverse; for example, a study reported two fetuses from the same mother were found to have the same variants but manifested different types of isomerism and cardiac lesions.41 The occurrence of different abnormalities may be higher in LAI but lower in RAI and vice versa. Ringle et al. (2021) reported different prevalence of cardiac morphological anomalies such as pulmonary atresia, ventriculoarterial connection, arterial trunks positioning, atypical distribution of coronary artery and single coronary artery, between LAI and RAI.42 In a study by Baban et al. (2018), it was found that 81 patients were classified as RAI and 55 patients as LAI. The long-term survival and freedom from heart transplant were higher in LAI patients compared to RAI patients, reaching 87.8% at 40 years for LAI and 69.8% for RAI.43

Congenital heart disease has implications on the outcomes of heterotaxy patients. Studies have shown that heterotaxy patients with CHD have increased postoperative mortality and respiratory complications.44 These patients have higher rates of tracheostomies, extracorporeal membrane oxygenation support, and prolonged ventilatory courses.45 Heterotaxy-CHD patients with respiratory ciliary dysfunction (CD) may have even worse postsurgical outcomes, including increased respiratory complications and the need for tracheostomy.38 Lim et al. (2005) reported that most left isomerism (LAI) cases required no intervention or underwent successful biventricular cardiac surgery, unlike right isomerism (RAI) cases. The study also found that patient age at initial surgery was an independent risk factor for mortality.46

The treatment and management strategy for heterotaxy-associated congenital heart disease patients is complex and varies depending on the specific cardiac malformations present. Surgical management is often necessary, and the choice of procedure depends on the anatomical abnormalities, including systemic and pulmonary venous connections. In cases of significant ventricular hypoplasia or extreme complexity, single ventricle palliation followed by the Fontan operation is commonly performed.29 HTX remains a challenging condition with high morbidity and mortality, particularly in patients with total anomalous pulmonary vein return and right ventricular outflow tract obstruction.8 Despite significant advancements in medical and surgical treatments for heterotaxy syndrome, the long-term prognosis for patients is still unsatisfactory.

The overall short-to-mid-term prognosis of heterotaxy patients is not satisfactory, however, multiple approaches including basic and clinical science are necessary to improve the prognosis and quality of life of heterotaxy patients. Systematic follow-up of the patients will improve their prognosis. Therefore, it can be inferred that the quality of life of heterotaxy patients can be affected by the complications associated with the disease, but it can be improved through better clinical management, tailor-made surgical operations, and systematic follow-up of the patients.30 Overall, a multidisciplinary approach involving pediatric and adult congenital heart disease specialists is crucial for the successful treatment and management of heterotaxy-associated congenital heart disease patients.

Suggested etiology

The etiology of HTX remains indefinite; however, effects from gene variants have been suggested, and genes related to ciliary function were studied the most.47 Disruption of the signaling pathway, mainly the Nodal signaling pathway, is another suggested etiology of HTX.15ZIC3 gene involvement in the Hedgehog signaling pathway and the canonical WNT signaling pathway has also been inferred.48 Environmental factors that might influence the etiology of heterotaxy include teratogenic exposures, especially maternal diabetes.49 Heterotaxy syndrome arises from the failure of intra-abdominal and intra-thoracic structures to rotate appropriately during embryologic development, which may occur due to a series of mutations in genes regulating the development of normal left–right axis determination.50

Ciliary function

Generally, human cilia are classified into two types: non-motile cilia (also known as primary cilia) and motile cilia. The critical function of primary cilia involves the signaling pathway and the regulation of the cellular environment, while respiratory tract mucous clearing, transport, and movement of cerebrospinal fluid, as well as gametocytes, are performed by the motile cilia.51 Dextrorotatory of the cilia produces a one-way nodal flow toward the left; hence transmission of determinant molecules is then toward the lateral plate mesoderm on the left, which produces left–right patterning asymmetry of the organs.9 Cilia generate leftward fluid flows in an embryonic “left–right organizer,” which directs asymmetric activation of the Nodal signaling pathway.52 This pathway guides the asymmetric morphogenesis of developing organs, including the heart.53 Studies in mice have shown that cilia transduced Hedgehog signaling coordinates left–right patterning with heart looping and differentiation of the heart tube.54

Studies on PCD or cilia dysfunction in HTX suggested that the genes involved in ciliary function play essential roles in determining the left–right patterning.6 Examples of genes involved in ciliary structure and function are DNAH11, DNAH5, DNAH7, and DNAI1.55 At the embryonic node, abnormalities in either motile or non-motile cilia may alter the left nodal flow, leading to HTX.51 About 12.1% of patients diagnosed with PCD and about 8.9% of patients without PCD were associated with HTX.56 A recent study by Liu et al. (2019) mentioned that roughly half of the patients with PCD were reported to have HTX associated with CHD.6 HTX and CHD are caused by multiple genes while PCD is a monogenic recessive illness with genetic heterogeneity.6,47 The connection between HTX, CHD and PCD needs to be investigated further, considering the effect of ciliary function on HTX and CHD from past studies.

Signaling pathways

Heterotaxy syndrome arises from intricate dysregulations in multiple signaling pathways during embryonic development. The Nodal, Hedgehog, and canonical WNT pathways play pivotal roles in establishing left–right asymmetry.57–59

The nodal signaling pathway is a significant component in left–right patterning determination during embryo development.60 In the Nodal signaling pathway, information is transmitted by type I and II receptors and EGF-CFC co-receptors, and the consequences of the receptor activation are SMAD2 and SMAD3 phosphorylation (Figure 2(A)).60,61 This enables SMAD2/SMAD3 binding to SMAD4, causing interactions with other transcription factors and target genes regulations in the nucleus. The heterodimeric SMAD complex may interact with DNA binding proteins (e.g. FOXH1 and MIXER) or simply bind to DNA.62 This process involves both extracellular and intracellular components.61 Proteins from the Nodal signaling pathway i.e., NODAL, LEFTY and PITX2 are expressed asymmetrically on the left side while LEFTY1 is expressed on the midline of the lateral plate mesoderm (LPM).15 The Nodal signaling pathway is dose sensitive, where any abnormality in signal transduction will affect Nodal expression, risking abnormal patterning and lead to HTX.62 Damaged Activin/Nodal-Smad signaling and reduction in signal transduction were observed in functional analysis of NODAL variants, supporting the dose sensitive hypothesis of the pathway.60,62 In an animal study, NODAL was found to have an important function in primitive streak and embryonic mesoderm development.63 To maintain balanced expression of Nodal, antagonists which are the Lefty proteins, act as negative feedback toward the Nodal expression.15,60 In a targeted study on mice, all four Lefty1 exons were removed using targeting vector, which resulted in abnormality of left–right patterning as Nodal was expressed bilaterally in the LPM.64 This supports the postulated mechanism of either the absence or bilateral expression of NODAL in NODAL signaling that causes HTX.62,64

Figure 2.

Three signaling pathways suggested to be involved in causing HTX. (A) Nodal signaling pathway. NODAL binds to its receptors (type 1, ActRII and type 2, ALK4) and co-receptor (EGF-CFC). SMAD2/3 are phosphorylated and bind with SMAD4, forming a complex. The SMAD complex enters the nucleus to regulate target genes transcription either by binding to the DNA binding protein or directly binds to the DNA. To keep the balance of NODAL expression, LEFTY acts as the negative feedback protein where it either binds to NODAL of the co-receptor when NODAL is expressed in abundance. Repression of the target genes may lead to absence or bilateral expression of NODAL leading to laterality defects and HTX. (B) Hedgehog signaling pathway. SMO inhibition by PTCH is lifted when Hh ligands bind to PTCH. This allows downstream cascade as SuFu stops its binding to GLI and GLI is able to enter the nucleus for target gene transcription. Binding of SuFu to GLI is a negative regulation of the pathway as the binding produces GLI-repressor. Presence of ZIC3 will inhibit the production of GLI-repressor and affect the gene transcription process in the nucleus. Repression of the IFT genes will cause disruption of the ciliary structure and function which also will cause laterality defects and HTX. (C) Canonical WNT signaling pathway. WNT binds to its receptor, FZD and co-receptor, LRP5/6. The binding induces dissociation of a complex consisting of APC, AXIN/DVL/GSK3/CK1/β-catenin. The result of the dissociation is the release of β-catenin which is then able to enter the nucleus to regulate target genes transcription by interacting with TCF. ZIC3 binding to TCF has the ability to repress β-catenin, hence affecting the WNT signaling pathway. It is suggested that β-catenin repression will give effect of suppressing the WNT pathway. Another suggested effect is reduction or accumulation of β-catenin. Both lead to failure in forming the dorsal axis, disrupting organ arrangements and cause HTX.

The Hedgehog signaling pathway is another significant component in mammals’ organ development where the Sonic Hedgehog (Shh), Indian-Hedgehog (Ihh) and Desert-Hedgehog (Dhh) are the three main Hedgehog proteins in the pathway.65 The binding of Hedgehog ligands to the PTCH will stop its inhibition on the SMO, hence allowing the downstream pathway. The downstream pathway includes interactions with GLI family (Figure 2(B)), where repressed SMO prevents GLI movement into the nucleus and retains it in the cytoplasm, by binding GLI to SuFu.65,66 The binding of GLI to SuFu does not only prevent target gene transcription by GLI but also leads to production of the GLI protein repressor by proteasome.48,67 ZIC3 interactions with the GLI in the pathway were found to cause alterations to the ratio of activator to repressor of GLI.48 The alterations of the GLI activator and repressor lead to target gene repression such as IFT genes (important for cilia structure and maintenance).67,68 Repression of the IFT genes leads to problems in the cilia structure and function,67,68 hence, causing HTX.

Apart from the Hedgehog signaling pathway, the WNT signaling pathway disruption was also inferred to have caused alterations to the left–right patterning. Asymmetry left–right patterning can be initiated by multiple WNT ligands.48 In the pathway, WNT binds to its receptor and co-receptor (FZD and LRP 5/6, respectively),which then initiates the dissociation of a complex (APC, AXIN/DVL/GSK3/CK1/β-catenin) and releases β-catenin from the complex (Figure 2(C)).69 β-Catenin interacts with TCF to regulate target genes transcription.48 Loss of Wnt3a in the dorsal posterior node, for example, causes aberrant left–right patterning due to delayed expression of certain proteins such as Nodal, Lefty2 and Pitx2 bilaterally in the LPM.70ZIC3 is one of the genes that has been suggested to have an effect on the WNT pathway leading to HTX.48 Fujimi et al. (2012) performed an animal study and discussed WNT signaling pathway suppression by ZIC3 and the effect of ZIC3 interaction in the pathway.71 They hypothesized that WNT signaling suppression by ZIC3 is tissue-specific as the observation of some mammalian cell lines did not show suppression of the WNT signaling.71 It is also hypothesized that ZIC3 interaction with TCF could repress WNT signaling.48 Reduction or overaccumulation of the maternal β-catenin leads to failure in dorsal axis development which is important in determining the arrangement of organs during embryogenesis.72

Dysfunctions in one pathway can influence the others, disrupting the precise coordination needed for proper left–right axis formation.73,74 For instance, variants in genes involved in the Nodal pathway, such as NODAL, ACVR1, and ACVR1B, can lead to abnormal Nodal signaling. This, in turn, affects Hedgehog signaling as Nodal induces the expression of Sonic Hedgehog (SHH) and reciprocally Hedgehog regulates Nodal-related genes.58,73 Concurrently, dysregulation in the canonical WNT pathway can impact the expression of Lefty proteins, key inhibitors of Nodal signaling.58 This disturbs the cross-talk between Nodal and canonical WNT pathways and influences Hedgehog signaling through altered SHH expression.74 The cumulative effects of these dysregulations disrupt the finely tuned interaction among the pathways, leading to the misalignment of internal organs, including the heart, and the manifestation of HTX. This asymmetry is also influenced by cilia activity and their role in creating the left–right organizer flow dynamics.75 It is crucial to note that HTX is a genetically heterogeneous condition, and not all cases can be attributed to variants in these pathways alone, indicating the involvement of other genetic and non-genetic factors in the development of the disorder.

Genes associated with heterotaxy syndrome

Previous studies have reported several genetic variants that are associated with HTX.41 HTX may be inherited by different modes depending on the genes that cause the condition.15Table 1 is a summary of the genes discussed in this review that are relevant to HTX.

Table 1.

Summary of the HTX-related genes discussed in this review.

Gene  DNAH11  DNAH5  ZIC3  NODAL  LEFTY2 
Location  7p15.3  5p15.2  Xq26.3  10q22.1  1q42.12 
Exon count  82  79 
Inheritance mode  Autosomal recessive  Autosomal recessive  X-linked recessive  Autosomal dominant  Autosomal dominant 
Function  Cilia structure formation  Cilia structure formation  GLI superfamily transcription factor  LR asymmetry determination during embryogenesis  Nodal antagonist 
OMIM ID  603339  603335  300265  601265  601877 
NCBI GeneID  8701  1767  7547  4838  7044 
Dynein axonemal heavy chain 11

DNAH11 is one of the genes responsible for forming the protein required in cilia structure. Apart from HTX, variants in DNAH11 are also linked to PCD.40 When comparing patients with and without CD, it was discovered that the mutation rate of the gene varied, with the rate of mutation being greater in patients with CD.6DNAH11 variants were predicted to affect splicing and have damaging effects on the protein, potentially leading to the development of heterotaxy and congenital heart defects.41 A study by Liu et al. (2019) found that out of a total of 34 variants, 14 were variants in the DNAH11 gene, which is the highest number of variants found in one gene in the study.6 In a family, two children were found to have the same DNAH11 variants (c.G3426-1A and c.C4306T); however, only the proband was affected with HTX while the other sibling was not.76 According to Xia et al. (2021), this occurrence is attributed by incomplete penetrance or the presence of other variants that inhibit the DNAH11 variants to develop HTX phenotypes.76

The variants are inherited in an autosomal recessive manner where various types of variants such as stop-gain, frameshift, missense, and splice site were reported.6,76Table 2 lists previously reported DNAH11 variants.

Table 2.

DNAH11 variants found to be associated with HTX in previous studies.

Type of variants  Base change  AA change  Cardiac/extracardiac defects  Ciliary  Ref. 
Stop-gain  c.G2406A  p.W802X  Isolated right heart, CAVC, DORV, ASDAbnormal ciliary function6
Missense  c.G846C  p.M282I 
Missense  c.C10379A  p.T3460K  CHDAbnormal ciliary function
Missense  c.G13273A  p.G4425S 
Missense  c.G1339A  p.G447R  CHDAbnormal ciliary function
Missense  c.T3470G  p.L1157R 
Missense  c.T6785C  p.I2262T  CHDCiliary dysfunction
Missense  c.G11398C  p.D3800H 
Frameshift  c.5470dupC  p.S1823fs  CHDCiliary dysfunction
Missense  c.T8275C  p.F2759L 
Stop-gain  c.C13183T  p.R4395X 
Missense  c.A10829T  p.D3610V  Isolated right heart, PA, L-TGA, ASDAbnormal ciliary function
Missense  c.A727G  p.I243V 
Frameshift  c.1648delA  p.Arg550Glyfs*16  RAI, unbalanced AVSD, hypoplastic left ventricle, PA, obstructed TAPV drainagePCD40
Missense  c.C11662T  p.R3888C 
Missense  c.G2772A  p.M924I 
Missense  c.C11662T  p.R3888C  LAI, dextrocardia, AVSD, interrupted IVCPCD
Frameshift  c.1648delA  p.Arg550Glyfs*16 
Splice site  c.3426-1G>A  p.Arg550Glyfs*16  CHD, single ventricle, incomplete TGA, pulmonary valve stenosis  NA  76 
Deletion  c.1306_67delCCT  p.4356delL  SA, bronchiectasis, otitis media, sinusitis, neonatal respiratory distressPCD77
Missense  c.C13075T  p.R4359X 
Missense  c.C10324T  p.Q3442X  SA, otitis media, sinusitis, neonatal respiratory distress  PCD 

ASD: atrial septal defect; CAVC: complete atrioventricular canal; CHD: congenital heart disease; DORV: double outlet right ventricle; IVC: inferior vena cava; LAI: left atrial isomerism; L-TGA: Levo-transposition of the great arteries; NA: not announced; PA: pulmonary atresia; PCD: primary ciliary dyskinesia; RAI: right atrial isomerism; SA: situs ambiguous; TAPV: total anomalous pulmonary venous; TGA: transposition of the great arteries.

Dynein axonemal heavy chain 5

Dynein axonemal heavy chain 5 is another gene that is associated with HTX due to its function in encoding proteins for the ciliary structure, specifically the outer dynein arm.78 It is mainly associated with PCD, and PCD caused by DNAH5 has been associated with laterality defects including situs ambiguous or HTX.78 The gene is inherited in an autosomal recessive manner and trans-heterozygosity of DNAH5 with DNAH6 and DNAH11 has been observed to cause HTX (Table 3).6,47

Table 3.

DNAH5 variants found to be associated with HTX in previous studies.

Type of variant  Base change  AA change  Cardiac defects  Ciliary/other defects  Ref. 
Missense  c.A7829G  p.E2610G  Common atrium, single ventricle, TAPV  Asplenia  79 
Missense  c.G1126T  p.A376S  Single atrium, single ventricle, pulmonary stenosis, SVCRight sided stomach, left-sided liver80
Missense  c.C2047T  p.R683W 
Missense  c.A737G  p.N246S  DORV, AVSD, PA*  Asplenia*  47
Missense  c.C12472T  p.R4158W  Single left ventricle*  Asplenia* 
Missense  c.C3514A  p.Q1172K  Single right ventricle*  Asplenia* 
Missense  c.A3086T  p.D1029V  Congenital heart disease**Immotile cilia  6
Missense  c.A10169G  p.D3390G  No cilia 
Missense  c.G13364T  p.G4455V  Restricted and discordance of cilia 
Missense  c.G12212A  p.R4071H  Restricted and discordance of cilia 

AVSD: atrioventricular septal defects; DORV: double outlet right ventricle; PA: pulmonary atresia; SVC: superior vena cava; TAPV: total anomalous pulmonary venous drainage.

*

The defects are of trans-heterozygous interactions between DNAH5 and DNAH6.

**

Further description of the cardiac defects is not available as only families with DNAH11 compound heterozygous were described in detail.

Zinc finger in cerebellum 3

Zinc finger in cerebellum 3 is a gene from the GLI superfamily that acts as a transcription factor during neurogenesis, and previous studies using animal models suggested that reduced expression and/or activity of ZIC3 protein during early embryogenesis affects the laterality patterning.81ZIC3 is a gene with significant evidence of its pathogenicity in causing HTX, where at least 36 ZIC3 variants have been discovered to be pathogenic since the first ZIC3 variant was found in 1997.82 Variants in the ZIC3 gene have been shown to have a significant impact on heterotaxy, particularly in male patients with abnormal arrangement of thoracic and visceral organs.81 These variants, which are predominantly located in the zinc finger domains or result in truncation before these domains, have been found to cause abnormal trafficking of mutated ZIC3 proteins.83 Functional analysis in zebrafish models has further confirmed the pathogenic nature of these variants, with frameshift variants showing full non-functionality and a missense variant showing partial activity compared to the wild-type.84 Additionally, variants in the N-terminal and zinc finger-binding domains of ZIC3 have been found to result in the loss of reporter gene transactivation and aberrant cytoplasmic localization, respectively.82

A functional investigation of a novel hemizygous mutation (c.890G>T, p.C297F) in the ZIC3 gene revealed that this specific mutation reduces the transcriptional activity of ZIC3. It affects the binding affinity of the GLI-binding site and leads to abnormal cellular localization when introduced into transfected cells. In addition, the variant (p.C297F) was found to affect protein structure and DNA-binding ability.82 Other than that, ZIC3 is the earliest gene associated with HTX reported and the only gene to be inherited by X-linked inheritance of HTX.83 D’alessandro et al. (2011) reported that the women in the studied family were carriers with no phenotypic manifestations, while several male family members manifested congenital heart diseases.85 One of the male family members was also found to carry the variant; however, no morphological defects of the organs were observed, which was confirmed to be due to incomplete penetrance of the ZIC3 gene variant.85 Five out of 100 familial HTX was found to be caused by ZIC3 variants, while 1 out of 100 were sporadic cases.35,85 Previously reported ZIC3 variants are listed in Table 4.

Table 4.

ZIC3 variants found to be associated with HTX in previous studies.

Type of variant  Base change  AA change  Cardiac defects  Other defects  Ref. 
Missense  c.890G>T  p.C297F  TGA, DORV  Asplenia, right stomach, left liver  82 
Frameshift  c.866dup  p.Glu291Glyfs*53  d-TGA, PA, CAVC  Abdominal SI, asplenia  86
Stop-gain  c.755C>A  p.Ser252*  Mesocardia, d-TGA, abnormal aortic arch, CoA, ASD, VSD, abnormal SVC  None 
Frameshift  c.593_609del  p.Pro198Glnfs*15  Dextrocardia, VSD  Absent stomach 
Nonsynonymous  c.1262T>A  p.Cys253Ser  RAI, HLHS, TGA, TAPVR  Asplenia, gut malrotation, abnormal liver lobation  34
Stop-gain  c.1250C>T  p.Gly249*  Common atrium, HLHS, PA, dextro ventricle, CAVC, bilateral SVC  Asplenia, tracheoesophageal fistula, imperforate anus, renal dysplasia 
Stop-gain  c.633C>A  p.Ser43*  CAVC, DORV, TGA, TAPVR, bilateral SVC  Asplenia, cholestasis with biliary atresia 
Missense  c.763T>G  p.W255G  d-TGA, single ventricle, PA, polysplenia  Polysplenia  87
Missense  c.763T>G  p.W255G  TGA, PA, mitral atresia  Asplenia 
Indels  c.18_19delinsA  p.Asp6GlufsX32  ASD, CAVC, PA  Gut malrotation, asplenia  83
Substitution  c.49G>T  p.G17C  None  Esophageal atresia 
Substitution  c.49G>T  p.G17C  Dextrocardia, single ventricle, PA, PAPVR, dilated aorta, RAA, ASD, VSD  Abdominal situs inversus 
Nonsense  c.463G>T  p.G155X  Dextrocardia, CAVC, PA, aortic arch, DORV, TAPVR, SVC abnormalities  Midline liver 
Nonsense  c.595-610delTACC  p.Tyr199delfsX19  Dextrocardia, VSD, ventriculomegaly  No stomach 
Missense  c.649C>G  p.P217A  Interrupted IVC  Gut malrotation, polysplenia, midline liver 
Missense  c.866dupG  p.Glu291GlyfsX53  CAVC, PA, d-TGA  Abdominal situs inversus 
Missense  c.1048A>G  p.R350G  Dextrocardia, LAI, interrupted IVC, LSVC to LA, CAVC, multiple VSD, pulmonary stenosis, RAA  Abdominal situs ambiguous, polysplenia, rectal duplication cyst, omphalocele  85 
Missense  c.49G>T  p.Gly17Cys  DORV, hypoplastic RV, malalignment VSD, CoA with arch hypoplasia  None  88
Missense  c.98C>T  p.Ala33Val  d-TGA  Pyloric stenosis 
Missense  c.841C>T  p.His281Tyr  Heterotaxy, single inlet VSD, TGA, PS and sub-PS  None 
Missense  c.876G>C  p.Gln292His  Absent IVC  Intestinal malrotation, polysplenia  89
Missense  c.889T>G  p.Cys297Gly  Left SVC and IVC, single atrium, CAVC, d-TGA, PA, right atrial and pulmonary isomerism  Intestinal malrotation, asplenia 
Frameshift  c.241_242dupTA  p.Ala82Thrfs*142  Heterotaxy  NA 
Substitution  c.1391A>G  p.H288R  Situs ambiguous  NA  90
Substitutionc.1502C>Tp.T325MSitus ambiguousOlfactory nerve aplasia (bilateral) 
Neural tube defect (lumbosacral spine) 
Cerebellar hypoplasia 
Duodenal stenosis 
Sacral agenesis 
Nonsense  c.1338C>A  p.C270X  Situs ambiguous  Sacral agenesis 
Nonsensec.1408C>Tp.Q294XSitus ambiguousDouble ureter (right) 
Horseshoe kidney, adrenal asplenia (left) 
Kidney hypoplasia and ureteral stenosis (left) 
Frameshift  c.148delG  p.A50PfsX8  Right ventricle dominant AVSD, DORV, mitral atresia, TAPVR  Malrotation, transverse liver, asplenia  91
Substitution  c.1204T>C  p.S402P  AVSD, PA, TAPVR, bilateral SVC with hepatic vein connecting to the midline of right atrium  Malrotation 
Substitution  c.1204T>C  p.S402P  Double inlet and double outlet single left ventricle, pulmonary stenosis, and RAA.  Situs inversus 

ASD: atrial septal defect; CAVC: complete atrioventricular canal; CoA: coarctation of the aorta; DORV: double outlet right ventricle; d-TGA: dextro-transposition of the great arteries; HLHS: hypoplastic left heart syndrome; IVC: inferior vena cava; LAI: left atrial isomerism; LSVC: left superior vena cava; NA: not announced; PA: pulmonary atresia; PAPVR: partial anomalous pulmonary venous return; PS: pulmonary stenosis; RAA: right aortic arch; RAI: right atrial isomerism; RV: right ventricle; SVC: superior vena cava; TAPVR: total anomalous pulmonary venous return; TGA: transposition of the great arteries; VSD: ventricle septal defect.

Nodal growth determination factor

NODAL protein is a secreted molecule from the Nodal signaling pathway. It is a regulator that belongs to the TGF-β family, hence it plays a significant role in the determination of left–right asymmetry in vertebrates.62 The expression of NODAL is primarily symmetry but progresses to asymmetrical toward the left side of the LPM, and the gene expression is highly conserved.92 Multiple studies have identified missense variants, in-frame insertion/deletion, and splice site variants in the NODAL gene in patients with heterotaxy and/or isolated cardiovascular malformations (CVM).62 Functional analyses have shown that these NODAL variants exhibit impaired signaling, leading to decreased activation of artificial reporters and reduced induction of SMAD2 phosphorylation and nuclear import.93 Additionally, a study on mouse mutants with a mutation in the MEGF8 gene, which is involved in left–right patterning, showed that Nodal signaling failed to be propagated to the left LPM, resulting in heterotaxy and CHD.94 These findings suggest that mutations and rare deleterious variants in NODAL can contribute to the development of sporadic human heterotaxy.95 A study by Mohapatra et al. (2009) found seven variants where four are missense, while one is in-frame insertion/deletion and two are splice site variants.62 Previously reported NODAL variants are listed in Table 5.

Table 5.

NODAL variants found to be associated with HTX in previous studies.

Type of variant  Base change  AA change  Cardiac defects  Other defects  Ref. 
Substitution  c.548G>A  p.Arg183Gln  NA  Situs ambiguous  92 
Insertion  c.700indel  p.R234_P241delinsLTS  d-TGA, single ventricle, DILV, PA, ASD, IART  None  62
Missense  c.778G>Ap.G206Rd-TGA, RAI, PA, PAPVR with pulmonary vein confluence, ASD, VSD, interrupted IVC with large hemiazygos vein draining to a left SVC  Abdominal situs inversus 
Missense  d-TGA, PA, ASD, single ventricle (LV morphology), PDA, IART  None 
Missense  d-TGA, single ventricle (RV morphology), single atrium, CAVC, PA, supracardiac TAPVR, primum ASD, LPA hypoplasia, IVC to LA, PDA, Wolf-Parkinson-White  Asplenia, abdominal situs inversus 
Missense  Dextrocardia, single ventricle (LV morphology), absent pulmonary trunk, TAPVR (to liver), ASD, persistent left SVC, bilateral IVC, each SVC and IVC drained into left and right atrium, respectively  Abdominal SI, bilateral trilobed lungs, asplenia, mild hydronephrosis 
Missense  d-TGA, single ventricle (RV morphology), PS, DORV, ASD, VSD  None 
Missense  d-TGA, ASD, PDA  None 
Missense  d-TGA, aortic arch hypoplasia, DORV, ASD, VSD, severe CoA, PDA  None 
Missense  Dextrocardia, d-TGA, dilated ascending aorta, PA, DILV, VSD, hypoplastic RV, criss-cross AV connections  None 
Missense  c.823C>T  p.R275C  d-TGA, CAVC, PA, AVVR, TAPVR, ASD  None 
Missense  c.850G>T  p.V284F  Dextrocardia, l-TGA, ventricular inversion, interrupted IVC, ventricular inversion, AV block, dilated cardiomyopathy  None 
Insertion  c.891+1 G>A  IVS2 splice ds  Dextrocardia, hypoplastic sub-pulmonary conus with PS, l-TGA, DORV with posterior main PA, VSD  None 

ASD: atrial septal defect; AV: atrioventricular; AVVR: atrioventricular valve regurgitation; CAVC: complete atrioventricular canal; CoA: coarctation of the aorta; DILV: double inlet left ventricle; DORV: double outlet right ventricle; d-TGA: dextro-transposition of the great artery; IART: intraarterial re-entrant tachycardia; IVC: inferior vena cava; LPA: left pulmonary artery; LV: left ventricle; l-TGA: Levo-transposition of the great arteries; NA: not announced; PA: pulmonary atresia; PAPVR: partial anomalous pulmonary venous return; PDA: patent ductus arteriosus; PS: pulmonary stenosis; RAI: right atrial isomerism; RV: right ventricle; SVC: superior vena cava; TAPVR: total anomalous pulmonary venous return; VSD: ventricle septal defect.

Left–right determinant factor

There are two LEFTY genes (LEFTY1 and LEFTY2), which are involved in Nodal signaling from node to the LPM.91LEFTY1 and LEFTY2 genes also belong to the TGF-β superfamily.93 They are NODAL antagonists in the Nodal signaling pathway, where they negatively regulate NODAL expression by blocking receptor complex activation.60 LEFTY1 is expressed in the midline of LPM while LEFTY2 is expressed within the left LPM, where both retain the NODAL signaling suppression.78 In one study, rare copy number variants (CNVs) were identified in patients with heterotaxy, and functional testing in zebrafish models revealed that downregulation of LEFTY disrupted cardiac looping and abnormal expression of left–right patterning markers.62 A nonsynonymous heterozygous variant pair of LEFTY1 (c.A841G) and TTC40 candidate gene were discovered in a CNV study.12 However, most LEFTY1 gene studies focus on gene expressions. Animal studies have revealed that the absence of Lefty1 affects both Nodal and Lefty2 genes expressions in which they are expressed on both sides of the lateral plates instead of only on the left side.64,91 Apart from LEFTY1, a study by Kosaki et al. (1999) found two sporadic variants (c.1025G>A and c.989C>T) of LEFTY2 cases that phenotypically fit the heterotaxy description.96 The variants were discovered to be in the cysteine knot region, which is critical as it directly implicates the binding of receptors.96 Two other LEFTY2 variants (c.-225C>T, ClinVarID: 295978, and c.-222C>A, ClinVarID: 295977) associated with HTX have been reported in the ClinVar database by Illumina, nevertheless no publications have reported these variants.97,98LEFTY2 is transcriptionally regulated by a complex which includes p300, SMAD2, and CITED2. Su et al. (2013), suggested that downregulation of LEFTY2 might play a role in the onset of VSD partly by triggering abnormal activation of the NODAL-PITX2C pathway.99 Additionally, the data reveal that the histone acetyltransferase p300 contributes to the activation of LEFTY2 by promoting hyperacetylation of histone H4 at the promoter region of LEFTY2. Previously reported LEFTY1 and LEFTY2 variants are listed in Table 6.

Table 6.

LEFTY1 and LEFTY2 variants found to be associated with HTX in previous studies.

Gene  Type of variant  Base change  AA change  Cardiac phenotype  Other phenotype  Ref. 
LEFTY1  Missense  c.A841G  p.Trp281Arg  Dextrocardia, DORV, Pulmonary stenosis, VSD, PDA, LSVC, SIV  RAA, bronchial inversus, right spleen, right-sided stomach, left-sided liver  12 
LEFTY2Missense  c.1025G>A  Ser342Lys  HLHS, CAVC, aortic atresia, left SVC to coronary sinus, right SVC to right atrium, inter-left IVC to the left atrium, right IVC to right atrium, pulmonary veins return to left atrium  Bilateral bilobed lungs, polysplenia, midline liver, right stomach, small intestine malposition  96
Nonsense  c.989C>T  Arg314*  RV-dominant CAVC, hypoplastic LV, dextrocardia, subaortic obstruction, CoA, left SVC to left-sided right atrium, inter-left IVC to left atrium, absent right SVC, inverted atrial appendages  Bilateral bilobed lungs, right liver, right stomach 

CAVC: complete atrioventricular canal: CoA: coarctation of the aorta: DORV: double outlet right ventricle: HLHS: hypoplastic left heart syndrome: IVC: inferior vena cava: LSVC: left superior vena cava: LV: left ventricle: PDA: patent ductus arteriosus: RAA: right aortic arch: RV: right ventricle: SIV: superior-inferior ventricle: SVC: superior vena cava: VSD: ventricle septal defect.

Other genes associated with heterotaxy including candidate genes

Based on NCBI NIH Genetic Testing Registry, HTX gene panel for diagnosis includes 10 genes, including NKX2-5, GDF1, GJA1, NODAL, CFC1, LEFTY2, ZIC3, CRELD1, FOXH1 and ACVR2B.100DNAI1, MMP21, PKD1L1, and HYDIN, are other known PCD genes associated with HTX besides those discussed above, while ROCK2, ISL1 and SMAD2 are newly found candidate genes.85

According to Litonjua and Celedón (2006), the definition of candidate gene is a gene that is suggested to have a link to a particular illness or trait by the discovery of either the protein products or chromosomal location.101 Further investigations are required to understand these genes better.

A study conducted using CNVs analysis suggested two candidate genes which are dynein axonemal heavy chain 10 (DNAH10) and ring finger protein 115 (RNF115), where DNAH10 was proposed to disrupt ciliary function as it affects notochord, while RNF115 affects the laterality signaling pathways.12 Six novel candidate genes were found in a study of 25 HTX patients, i.e., FLNA, ITGA1, PCNT, KIF7, GLI1, and KMT2D.102KIF7 and FLNA are indirectly involved in the ciliary movement as KIF7 encodes for cilia associated protein in the Shh signaling pathway, while FLNA encodes for actin-binding proteins involved in cytoskeleton function.102 Apart from the genes discussed in the review, homozygous missense mutation of SHROOM3 gene (c.G179T) was reported in a study; however, the variant cannot be found in the databases.103 In addition, PFKP is among the top HTX candidate genes with proof of its effect in an animal model, Xenopus laevis.13PITX2 expression is important for the formation of the heart, and its abnormal expression has been linked to CHDs.104 Studies in animal models further support the connection of abnormal expression of PITX2 with HTX.105,106

Current limitations and future research directions

The quest to unravel the genetic underpinnings of HTX and CHD is a challenging yet rewarding endeavor. At present, our understanding is substantial but constrained by several limitations. Predominantly, genetic studies exhibit an inclination toward populations of European ancestry, thereby narrowing the diversity and generalizability of the findings. Most identified genetic factors are inferred from association studies, which primarily establish a correlation rather than causation. Establishing causality requires extensive functional studies, which are often impeded by time and resource constraints. The genetics of HTX and CHD represent a complex interplay of multiple genes and environmental factors, adding layers of intricacy to the understanding of these conditions. Additionally, the role of epigenetic factors in HTX and CHD is relatively nascent, necessitating further exploration.

Despite these hurdles, the prospective avenues in HTX and CHD genetic research hold immense promise. Emerging methodologies, including genome-wide association studies and whole exome sequencing, are expected to uncover novel genetic factors. An in-depth exploration of gene–gene and gene–environment interactions is expected to provide a more comprehensive understanding of these conditions. One area of particular interest is the genetic basis of CHD in the context of HTX, which may elucidate why certain individuals develop CHD while others do not. Progress in our understanding could pave the way for targeted therapies and precision medicine, revolutionizing the treatment landscape. The role of epigenetic factors, such as DNA methylation, histone modifications and noncoding RNA activity, represents another promising research frontier. Functional studies of genetic variants associated with HTX and CHD are expected to shed light on the mechanisms through which these variants alter cellular functions and contribute to disease pathogenesis. The path forward, while fraught with challenges, is replete with opportunities for significant breakthroughs and advancements.

Conclusion

Heterotaxy syndrome is commonly associated with complex CHD that accounts for significant morbidity and mortality. Currently, multiple HTX-related genes are being discovered and their association elucidated, including their inheritance patterns of either autosomal recessive, autosomal dominant, or X-linked inheritance. HTX's etiology is hard to understand due to the multiple genes that can possibly be associated with HTX. The phenotypic defects between the RAI and LAI may be determined generally; however, further research should be conducted as there are overlapping cardiac defects among them. Disruption of ciliary function has been observed to have caused the abnormal expression of certain proteins during embryogenesis, leading to abnormal organ arrangement. Apart from that, signaling pathway disruptions due to gene variants are inferred to have been one of the HTX etiology. Nevertheless, further studies are required to validate them and consider the possibility of environmental factors being involved.

Conflict of interest

No potential conflict of interest was reported by the authors.

Acknowledgment

We would like to thank Ms. Ana Leticia Gomes for her invaluable assistance in translating the English language abstract into Portuguese.

References
[1]
D.I.P. Buca, A. Khalil, G. Rizzo, et al.
Outcome of prenatally diagnosed fetal heterotaxy: systematic review and meta-analysis.
Ultrasound Obstet Gynecol, 51 (2018), pp. 323-330
[2]
R.H. Anderson, D.E. Spicer, R. Loomba.
Is an appreciation of isomerism the key to unlocking the mysteries of the cardiac findings in heterotaxy?.
J Cardiovasc Dev Dis, 5 (2018), pp. 11
[3]
S. Mishra, S. Thakur.
Heterotaxy syndrome.
A comprehensive approach to congenital heart disease, pp. 145
[4]
C.D. Wolla, A.M. Hlavacek, U.J. Schoepf, et al.
Cardiovascular manifestations of heterotaxy and related situs abnormalities assessed with CT angiography.
J Cardiovasc Comput Tomogr, 7 (2013), pp. 408-416
[5]
D. van der Linde, E.E. Konings, M.A. Slager, et al.
Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.
J Am Coll Cardiol, 58 (2011), pp. 2241-2247
[6]
S. Liu, W. Chen, Y. Zhan, et al.
DNAH11 variants and its association with congenital heart disease and heterotaxy syndrome.
[7]
H. Deng, H. Xia, S. Deng.
Genetic basis of human left–right asymmetry disorders.
Expert Rev Mol Med, 16 (2015), pp. e19
[8]
A. Serraf, N. Bensari, L. Houyel, et al.
Surgical management of congenital heart defects associated with heterotaxy syndrome.
Eur J Cardiothorac Surg, 38 (2010), pp. 721-727
[9]
I. Shiraishi, H. Ichikawa.
Human heterotaxy syndrome – from molecular genetics to clinical features, management, and prognosis.
Circ J, 76 (2012), pp. 2066-2075
[10]
A.C. Jelin, N. Vora.
Whole exome sequencing: applications in prenatal genetics.
Obstet Gynecol Clin North Am, 45 (2018), pp. 69-81
[11]
M.P. Kennedy, H. Omran, M.W. Leigh, et al.
Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia.
Circulation, 115 (2007), pp. 2814-2821
[12]
C. Liu, R. Cao, Y. Xu, et al.
Rare copy number variants analysis identifies novel candidate genes in heterotaxy syndrome patients with congenital heart defects.
[13]
J.R. Cowan, M. Tariq, C. Shaw, et al.
Copy number variation as a genetic basis for heterotaxy and heterotaxy-spectrum congenital heart defects.
Philos Trans R Soc Lond B Biol Sci, 371 (2016),
[14]
L. Zhu, J.W. Belmont, S.M. Ware.
Genetics of human heterotaxias.
Eur J Hum Genet, 14 (2006), pp. 17-25
[15]
M.J. Sutherland, S.M. Ware.
Disorders of left–right asymmetry: heterotaxy and situs inversus.
Am J Med Genet C Semin Med Genet, 151C (2009), pp. 307-317
[16]
J.P. Jacobs, R.H. Anderson, P.M. Weinberg, et al.
The nomenclature, definition and classification of cardiac structures in the setting of heterotaxy.
Cardiol Young, 17 (2007), pp. 1-28
[17]
M.Y. Lee, H.S. Won, J.Y. Shim, et al.
Prenatal diagnosis of atrial isomerism in the Korean population.
Obstet Gynecol Sci, 57 (2014), pp. 193-200
[18]
A. Fotaki, V.L. Doughty, W. Banya, et al.
Impact of gastrointestinal comorbidities in patients with right and left atrial isomerism.
Cardiol Young, 32 (2022), pp. 1053-1060
[19]
C. Berg, A. Geipel, D. Kamil, et al.
The syndrome of left isomerism: sonographic findings and outcome in prenatally diagnosed cases.
J Ultrasound Med, 24 (2005), pp. 921-931
[20]
C. Berg, A. Geipel, J. Smrcek, et al.
Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience.
Ultrasound Obstet Gynecol, 22 (2003), pp. 451-459
[21]
B. Champaneri, P. Agrawal, M. Jain, et al.
Comparison of morphologic profile of congenital heart defects associated with right isomerism and left isomerism in Western Indian population.
Heart India, 8 (2020), pp. 26-29
[22]
J.H. Lin, C.I. Chang, J.K. Wang, et al.
Intrauterine diagnosis of heterotaxy syndrome.
Am Heart J, 143 (2002), pp. 1002-1008
[23]
Y.L. Yan, K.B. Tan, G.S. Yeo.
Right atrial isomerism: preponderance in Asian fetuses. Using the stomach–distance ratio as a possible diagnostic tool for prediction of right atrial isomerism.
Ann Acad Med Singap, 37 (2008), pp. 906-912
[24]
H.K. Gill, M. Splitt, G.K. Sharland, et al.
Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography.
J Am Coll Cardiol, 42 (2003), pp. 923-929
[25]
G.D. Williams, A. Feng.
Heterotaxy syndrome: implications for anesthesia management.
J Cardiothorac Vasc Anesth, 24 (2010), pp. 834-844
[26]
S.S. Kothari.
Non-cardiac issues in patients with heterotaxy syndrome.
Ann Pediatr Cardiol, 7 (2014), pp. 187-192
[27]
P. Banka, A. Adar, B. Schaetzle, et al.
Changes in prognosis of heterotaxy syndrome over time.
Pediatrics, 146 (2020),
[28]
S. Yan, W. Jianpeng, Q. Xin, et al.
Right atrial isomerism in children older than 3 years.
Springerplus, 5 (2016), pp. 1372
[29]
P.I. Abbas, H.A. Dickerson, D.E. Wesson.
Evaluating a management strategy for malrotation in heterotaxy patients.
J Pediatr Surg, 51 (2016), pp. 859-862
[30]
I. Shiraishi, H. Ichikawa.
Human heterotaxy syndrome – from molecular genetics to clinical features, management, and prognosis.
Circ J, 76 (2012), pp. 2066-2075
[31]
S. Kharel, D.P. Koirala, S. Shrestha, et al.
Heterotaxy syndrome with complex congenital heart disease, facial palsy, and asplenia: a rare newborn finding.
Clin Case Rep, 9 (2021),
[32]
A.M. Alongi, J.K. Kirklin, L. Deng, et al.
Surgical management of heterotaxy syndrome: current challenges and opportunities.
World J Pediatr Congenit Heart Surg, 11 (2020), pp. 166-176
[33]
J. Rychik, Z. Tian.
Fetal cardiovascular imaging: a disease-based approach: expert consult premium..
1st ed., Elsevier Health Sciences, (2011),
[34]
H. Peeters, K. Devriendt.
Human laterality disorders.
Eur J Med Genet, 49 (2006), pp. 349-362
[35]
R.J. Francis, A. Christopher, W.A. Devine, et al.
Congenital heart disease and the specification of left–right asymmetry.
Am J Physiol Heart Circ Physiol, 302 (2012),
[36]
A.U. Qureshi, U. Kazmi, T. Kazmi, et al.
Congenital heart defects associated with atrial heterotaxy.
J Coll Physicians Surg Pak, 22 (2012), pp. 549-552
[37]
P.V. Anagnostopoulos, J.M. Pearl, C. Octave, et al.
Improved current era outcomes in patients with heterotaxy syndromes.
Eur J Cardiothorac Surg, 35 (2009), pp. 871-877
[38]
R. Agarwal, R. Varghese, V. Jesudian, et al.
The heterotaxy syndrome: associated congenital heart defects and management.
Indian J Thorac Cardiovasc Surg, 37 (2021), pp. 67-81
[39]
V.S. Kiran, S. Choudhary, A. Shaik, et al.
The spectrum of cardiac anomalies associated with heterotaxy: a single-center study of a large series based on computed tomography.
Pediatr Cardiol, 41 (2020), pp. 1414-1424
[40]
S.M. Ware, J. Peng, L. Zhu, et al.
Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects.
Am J Hum Genet, 74 (2004), pp. 93-105
[41]
A. Namavarian, A. Eid, E.S.Y. Goh, et al.
A novel DNAH11 variant segregating in a sibship with heterotaxy and implications for genetic counseling.
Mol Genet Genom Med, 8 (2020),
[42]
M.L. Ringle, R. Loomba, J.C. Dykes, et al.
The multisystem nature of isomerism: left isomerism complicated by Abernethy malformation and portopulmonary hypertension.
Cardiol Young, 31 (2021), pp. 532-540
[43]
A. Baban, N. Cantarutti, R. Adorisio, et al.
Long-term survival and phenotypic spectrum in heterotaxy syndrome: a 25-year follow-up experience.
Int J Cardiol, 268 (2018), pp. 100-105
[44]
M. Swisher, R. Jonas, X. Tian, et al.
Increased postoperative and respiratory complications in patients with congenital heart disease associated with heterotaxy.
J Thorac Cardiovasc Surg, 141 (2011), pp. 637-644
[45]
A. Khan, E. Pahl, D.A. Koehl, et al.
Improved heart transplant survival for children with congenital heart disease and heterotaxy syndrome in the current era: an analysis from the pediatric heart transplant society.
J Heart Lung Transplant, 40 (2021), pp. 1153-1163
[46]
J.S. Lim, B.W. McCrindle, J.F. Smallhorn, et al.
Clinical features, management, and outcome of children with fetal and postnatal diagnoses of isomerism syndromes.
Circulation, 112 (2005), pp. 2454-2461
[47]
Y. Li, H. Yagi, E.O. Onuoha, et al.
DNAH6 and its interactions with PCD genes in heterotaxy and primary ciliary dyskinesia.
PLoS Genet, 12 (2016), pp. e1005821
[48]
H.M. Bellchambers, S.M. Ware.
ZIC3 in heterotaxy.
Adv Exp Med Biol, 1046 (2018), pp. 301-327
[49]
J.W. Belmont, B. Mohapatra, J.A. Towbin, et al.
Molecular genetics of heterotaxy syndromes.
Curr Opin Cardiol, 19 (2004), pp. 216-220
[50]
J. Lovell, J. Sivakumar, S. Wijeratne.
Incidental abdominal heterotaxy syndrome.
ANZ J Surg, 90 (2020), pp. 911-912
[51]
M.J. Harrison, A.J. Shapiro, M.P. Kennedy.
Congenital heart disease and primary ciliary dyskinesia.
Paediatr Respir Rev, 18 (2016), pp. 25-32
[52]
T.G. Saba, A.J. Shapiro.
Pulmonary complications of heterotaxy syndromes.
Pulmonary complications of non-pulmonary pediatric disorders. Respiratory medicine, pp. 219-240
[53]
G.C. Gabriel, C.B. Young, C.W. Lo.
Role of cilia in the pathogenesis of congenital heart disease.
Semin Cell Dev Biol, 110 (2021), pp. 2-10
[54]
A. Dasgupta, J.D. Amack.
Cilia in vertebrate left–right patterning.
Philos Trans R Soc Lond B Biol Sci, 371 (2016),
[55]
M.A. Zariwala, M.R. Knowles, H. Omran.
Genetic defects in ciliary structure and function.
Annu Rev Physiol, 69 (2007), pp. 423-450
[56]
A.J. Shapiro, S.D. Davis, T. Ferkol, et al.
Genetic disorders of mucociliary clearance consortium. Laterality defects other than situs inversus totalis in primary ciliary dyskinesia: insights into situs ambiguus and heterotaxy.
Chest, 146 (2014), pp. 1176-1186
[57]
A.F. Ramsdell.
Left–right asymmetry and congenital cardiac defects: getting to the heart of the matter in vertebrate left–right axis determination.
[58]
M.M. Shen.
Nodal signaling: developmental roles and regulation.
Development, 134 (2007), pp. 1023-1034
[59]
H. Hamada, P.P. Tam.
Mechanisms of left–right asymmetry and patterning: driver, mediator and responder.
F1000Prime Rep, 6 (2014), pp. 110
[60]
R.M. Barnes, B.L. Black.
Nodal signaling and congenital heart defects.
Etiology and morphogenesis of congenital heart disease: from gene function and cellular interaction to morphology [internet],
[61]
A.F. Schier.
Nodal morphogens.
Cold Spring Harb Perspect Biol, 1 (2009),
[62]
B. Mohapatra, B. Casey, H. Li, et al.
Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations.
Hum Mol Genet, 18 (2009), pp. 861-871
[63]
Y.T. Yan, J.J. Liu, Y. Luo, et al.
Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
Mol Cell Biol, 22 (2002), pp. 4439-4449
[64]
C. Meno, A. Shimono, Y. Saijoh, et al.
Lefty-1 is required for left–right determination as a regulator of lefty-2 and nodal.
Cell, 94 (1998), pp. 287-297
[65]
G.B. Carballo, J.R. Honorato, G.P.F. de Lopes, et al.
A highlight on sonic hedgehog pathway.
Cell Commun Signal, 16 (2018), pp. 11
[66]
Z. Choudhry, A.A. Rikani, A.M. Choudhry, et al.
Sonic hedgehog signalling pathway: a complex network.
Ann Neurosci, 21 (2014), pp. 28-31
[67]
E.E. Davis, M. Brueckner, N. Katsanis.
The emerging complexity of the vertebrate cilium: new functional roles for an ancient organelle.
Dev Cell, 11 (2006), pp. 9-19
[68]
D. Huangfu, K.V. Anderson.
Cilia and Hedgehog responsiveness in the mouse.
Proc Natl Acad Sci U S A, 102 (2005), pp. 11325-11330
[69]
K. Yang, X. Wang, H. Zhang, et al.
The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies.
Lab Invest, 96 (2016), pp. 116-136
[70]
M.A. Nakaya, K. Biris, T. Tsukiyama, et al.
Wnt3a links left–right determination with segmentation and anteroposterior axis elongation.
Development, 132 (2005), pp. 5425-5436
[71]
T.J. Fujimi, M. Hatayama, J. Aruga.
Xenopus Zic3 controls notochord and organizer development through suppression of the Wnt/β-catenin signaling pathway.
Dev Biol, 361 (2012), pp. 220-231
[72]
L. Zeng, F. Fagotto, T. Zhang, et al.
The mouse fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation.
[73]
H. Hamada, C. Meno, D. Watanabe, et al.
Establishment of vertebrate left–right asymmetry.
Nat Rev Genet, 3 (2002), pp. 103-113
[74]
T. Nakamura, H. Hamada.
Left–right patterning: conserved and divergent mechanisms.
Development, 139 (2012), pp. 3257-3262
[75]
P. Sampaio, R.R. Ferreira, A. Guerrero, et al.
Left–right organizer flow dynamics: how much cilia activity reliably yields laterality?.
Dev Cell, 29 (2014), pp. 716-728
[76]
H. Xia, X. Huang, S. Deng, et al.
DNAH11 compound heterozygous variants cause heterotaxy and congenital heart disease.
PLoS One, 16 (2021),
[77]
M.R. Knowles, M.W. Leigh, J.L. Carson, et al.
Genetic disorders of mucociliary clearance consortium. mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure.
Thorax, 67 (2012), pp. 433-441
[78]
T. Nöthe-Menchen, J. Wallmeier, P. Pennekamp, et al.
Randomization of left–right asymmetry and congenital heart defects: the role of DNAH5 in humans and mice.
Circ Genom Precis Med, 22 (2019),
[79]
G. Tate, T. Tajiri, K. Kishimoto, et al.
A novel mutation of the axonemal dynein heavy chain gene 5 (DNAH5) in a Japanese neonate with asplenia syndrome.
Med Mol Morphol, 48 (2015), pp. 116-122
[80]
T. Yi, H. Sun, Y. Fu, et al.
Genetic and clinical features of heterotaxy in a prenatal cohort.
Front Genet, 13 (2022), pp. 818241
[81]
A.D. Paulussen, A. Steyls, J. Vanoevelen, et al.
Rare novel variants in the ZIC3 gene cause X-linked heterotaxy.
Eur J Hum Genet, 24 (2016), pp. 1783-1791
[82]
S. Li, S. Liu, W. Chen, et al.
A novel ZIC3 gene mutation identified in patients with heterotaxy and congenital heart disease.
[83]
J. Cowan, M. Tariq, S.M. Ware.
Genetic and functional analyses of ZIC3 variants in congenital heart disease.
Hum Mutat, 35 (2014), pp. 66-75
[84]
S.M. Ware, J. Peng, L. Zhu, et al.
Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects.
Am J Hum Genet, 74 (2004), pp. 93-105
[85]
L.C. D’Alessandro, B. Casey, V.M. Siu.
Situs inversus totalis and a novel ZIC3 mutation in a family with X-linked heterotaxy.
Congenit Heart Dis, 8 (2013), pp. E36-E40
[86]
A.H. Li, N.A. Hanchard, M. Azamian, et al.
Genetic architecture of laterality defects revealed by whole exome sequencing.
Eur J Hum Genet, 27 (2019), pp. 563-573
[87]
B. Chhin, M. Hatayama, D. Bozon, et al.
Elucidation of penetrance variability of a ZIC3 mutation in a family with complex heart defects and functional analysis of ZIC3 mutations in the first zinc finger domain.
Hum Mutat, 28 (2007), pp. 563-570
[88]
L.C. D’Alessandro, B.C. Latney, P.C. Paluru, et al.
The phenotypic spectrum of ZIC3 mutations includes isolated d-transposition of the great arteries and double outlet right ventricle.
Am J Med Genet A, 161A (2013), pp. 792-802
[89]
R. El Malti, H. Liu, B. Doray, et al.
A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field.
Eur J Hum Genet, 24 (2016), pp. 228-236
[90]
M. Gebbia, G.B. Ferrero, G. Pilia, et al.
X-linked situs abnormalities result from mutations in ZIC3.
Nat Genet, 17 (1997), pp. 305-308
[91]
L. Ma, E.S. Selamet Tierney, T. Lee, et al.
Mutations in ZIC3 and ACVR2B are a common cause of heterotaxy and associated cardiovascular anomalies.
Cardiol Young, 22 (2012), pp. 194-201
[92]
A. Catana, A.P. Apostu.
The determination factors of left–right asymmetry disorders- a short review.
Clujul Med, 90 (2017), pp. 139-146
[93]
J.F. Martin, B.A. Amendt, N.A. Brown.
Pitx2 in cardiac left–right asymmetry and human disease.
Heart Dev Regen, (2010), pp. 307-322
[94]
Z. Zhang, D. Alpert, R. Francis, et al.
Massively parallel sequencing identifies the gene Megf8 with ENU-induced mutation causing heterotaxy.
Proc Natl Acad Sci U S A, 106 (2009), pp. 3219-3224
[95]
A. Le Fevre, J. Baptista, S. Ellard, et al.
Compound heterozygous Pkd1l1 variants in a family with two fetuses affected by heterotaxy and complex Chd.
Eur J Med Genet, 63 (2020), pp. 103657
[96]
K. Kosaki, M.T. Bassi, R. Kosaki, et al.
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left–right axis development.
Am J Hum Genet, 64 (1999), pp. 712-721
[97]
National Center for Biotechnology Information. ClinVar; [VCV000295977.7]. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000295977.7. [Accessed 9 August 2023].
[98]
National Center for Biotechnology Information. ClinVar; [VCV000295978.7]. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000295978.7. [Accessed 9 August 2023].
[99]
D. Su, Q. Li, L. Guan, et al.
Down-regulation of EBAF in the heart with ventricular septal defects and its regulation by histone acetyltransferase p300 and transcription factors smad2 and cited2.
Biochim Biophys Acta, 1832 (2013), pp. 2145-2152
[100]
National Center for Biotechnology Information. Genetic Testing Registry; [521334]. Available from: https://www.ncbi.nlm.nih.gov/gtr/tests/521334/. [Accessed 9 August 2023].
[101]
A.A. Litonjua, J.C. Celedón.
GENETICS | Gene Association Studies..
Encyclopedia of Respiratory Medicine., pp. 240-247
[102]
S. Liang, X. Shi, C. Yu, et al.
Identification of novel candidate genes in heterotaxy syndrome patients with congenital heart diseases by whole exome sequencing.
Biochim Biophys Acta Mol Basis Dis, 1866 (2020), pp. 165906
[103]
M. Tariq, J.W. Belmont, S. Lalani, et al.
SHROOM3 is a novel candidate for heterotaxy identified by whole exome sequencing.
Genome Biol, 12 (2011), pp. R91
[104]
A. Naaraayan, A. Nimkar, P. Acharya, et al.
When right is wrong!.
J Atr Fibrillation, 13 (2020), pp. 2222
[105]
D.T. Grimes, R.D. Burdine.
Left–right patterning: breaking symmetry to asymmetric morphogenesis.
Trends Genet, 33 (2017), pp. 616-628
[106]
D. Franco, D. Sedmera, E. Lozano-Velasco.
Multiple roles of Pitx2 in cardiac development and disease.
J Cardiovasc Dev Dis, 4 (2017), pp. 16
Copyright © 2025. Sociedade Portuguesa de Cardiologia
Baixar PDF
Idiomas
Revista Portuguesa de Cardiologia
Opções de artigo
Ferramentas
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico revista@spc.pt. Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.